Donate
Call the Lung HelpLine
Ask a Question
The following text field filters the results that follow as you type. Use Tab to access the results.
  1. Home
  2. Research & Reports
  3. About Our Research
  4. Research News
  5. Kynureninase Upregulation Is a Prominent Feature of NFR2-Activated Cancers

Kynureninase Upregulation Is a Prominent Feature of NFR2-Activated Cancers and Is Associated with Tumor Immunosuppression and Poor Prognosis

Cancers | January 29, 2023

This study found that an enzyme called kynureninase is a reliable marker of tumor immunosuppression in lung adenocarcinoma, and high levels of this enzyme indicate poor prognosis and survival. This is an important discovery of a biomarker that could help with early detection of many cancers and will lead to future research in the therapeutic potential of targeting this enzyme.  Co-author Edwin Ostrin, MD, PhD, was funded by the Lung Cancer Discovery Award.
Freedom From Smoking Clinic - Richmond, VA
Richmond, VA | May 05, 2025
See All Events